V020-0139 Screening compound: 4-(3-CHLORO-4-FLUOROPHENYL)-N6-[2-(MORPHOLIN-4-YL)ETHYL]-2-PHENYL-2H-PYRAZOLO[3,4-D]PYRIMIDINE-3,6-DIAMINE

V020-0139 Screening compound: 4-(3-CHLORO-4-FLUOROPHENYL)-N6-[2-(MORPHOLIN-4-YL)ETHYL]-2-PHENYL-2H-PYRAZOLO[3,4-D]PYRIMIDINE-3,6-DIAMINE
V020-0139 Screening compound: 4-(3-CHLORO-4-FLUOROPHENYL)-N6-[2-(MORPHOLIN-4-YL)ETHYL]-2-PHENYL-2H-PYRAZOLO[3,4-D]PYRIMIDINE-3,6-DIAMINE alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-0139
4-(3-CHLORO-4-FLUOROPHENYL)-N6-[2-(MORPHOLIN-4-YL)ETHYL]-2-PHENYL-2H-PYRAZOLO[3,4-D]PYRIMIDINE-3,6-DIAMINE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-0139

Molecular Formula

C23H23ClFN7O (C23 H23 ClFN7 O)

Compound Name

4-(3-CHLORO-4-FLUOROPHENYL)-N6-[2-(MORPHOLIN-4-YL)ETHYL]-2-PHENYL-2H-PYRAZOLO[3,4-D]PYRIMIDINE-3,6-DIAMINE

IUPAC name

n/a

SMILES

Nc1c2c(-c(cc3)cc(Cl)c3F)nc(NCCN3CCOCC3)nc2nn1-c1ccccc1

InChI

InChI=1S/C23H23ClFN7O/c24-17-14-15(6-7-18(17)25)20-19-21(26)32(16-4-2-1-3-5-16)30-22(19)29-23(28-20)27-8-9-31-10-12-33-13-11-31/h1-7,14H,8-13,26H2,(H,27,29,30)

InChI Key

CEZGGNAHVUPBFI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14249966

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

467.93

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.577

Distribution Coefficient, logD

3.488

Water Solubility, LogSw

-4.10

Polar Surface Area

76.543

Acid Dissociation Constant (pKa)

17.85

Base Dissociation Constant (pKb)

6.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.10

V020-0139 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V020-0139 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-0139?
Check Price and Availability of V020-0139, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-0139 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-0139
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-0139
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-0139 available by request